Todd M. Morgan, MD, is a urologist and urologic oncologist specializing in surgical and precision-based care for patients with genitourinary cancers. He is the Jack Lapides M.D. Research Professor, Professor of Urology and Urologic Oncology, and Division Chief of Urologic Oncology at the University of Michigan Medical School, where he is also a member of the Rogel Cancer Center and Taubman Institute. His clinical practice focuses on urologic oncology, advanced robotic and minimally invasive surgery, and personalized treatment planning informed by molecular diagnostics. As a translational surgeon-scientist, Dr. Morgan’s research centers on precision oncology in urologic cancers. His scholarly interests include liquid biopsy and circulating tumor cell profiling, tissue-based biomarkers and genomic testing, and molecular risk stratification to better guide treatment selection and response assessment. Dr. Morgan has earned national recognition for leadership and advocacy, including the ASPI Special Award for Advocacy, the Society of Urologic Oncology Young Investigator Award, and additional young investigator honors from the Prostate Cancer Foundation, NCCN, and the Society for Basic Urology Research. He has served as president of the Young Urologic Oncologists of the Society of Urologic Oncology, contributes to major national guideline panels for AUA, ASCO, and NCCN, and is an associate editor for European Urology. He received his medical degree from Harvard Medical School, completed his urology residency at the University of Washington Medical Center, and pursued fellowship training in urologic oncology at Vanderbilt University Medical Center.
Division Chief
Medical School
1999 – 2003
Residency
2003 – 2004
Fellowship
2009 – 2011